315 related articles for article (PubMed ID: 25532041)
1. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth.
Chan CL; Pyle L; Newnes L; Nadeau KJ; Zeitler PS; Kelsey MM
J Clin Endocrinol Metab; 2015 Mar; 100(3):902-10. PubMed ID: 25532041
[TBL] [Abstract][Full Text] [Related]
2. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
3. HbA1c Cutoff for Prediabetes and Diabetes Based on Oral Glucose Tolerance Test in Obese Children and Adolescents.
Nam HK; Cho WK; Kim JH; Rhie YJ; Chung S; Lee KH; Suh BK
J Korean Med Sci; 2018 Mar; 33(12):e93. PubMed ID: 29542302
[TBL] [Abstract][Full Text] [Related]
4. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring.
Barron CVM; Heenan HF; Thompson H; Chan H; Ngu J; Lunt H
Diabet Med; 2022 Mar; 39(3):e14778. PubMed ID: 34957598
[TBL] [Abstract][Full Text] [Related]
5. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
[TBL] [Abstract][Full Text] [Related]
6. Increased hemoglobin A1c threshold for prediabetes remarkably improving the agreement between A1c and oral glucose tolerance test criteria in obese population.
Li J; Ma H; Na L; Jiang S; Lv L; Li G; Zhang W; Na G; Li Y; Sun C
J Clin Endocrinol Metab; 2015 May; 100(5):1997-2005. PubMed ID: 25751104
[TBL] [Abstract][Full Text] [Related]
7. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
[TBL] [Abstract][Full Text] [Related]
8. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
9. Continuous glucose monitoring is more sensitive than HbA1c and fasting glucose in detecting dysglycaemia in a Spanish population without diabetes.
Rodriguez-Segade S; Rodriguez J; Camiña F; Fernández-Arean M; García-Ciudad V; Pazos-Couselo M; García-López JM; Alonso-Sampedro M; González-Quintela A; Gude F
Diabetes Res Clin Pract; 2018 Aug; 142():100-109. PubMed ID: 29807103
[TBL] [Abstract][Full Text] [Related]
10. Discordance Between Glucose Levels Measured in Interstitial Fluid
Færch K; Amadid H; Bruhn L; Clemmensen KKB; Hulman A; Ried-Larsen M; Blond MB; Jørgensen ME; Vistisen D
Front Endocrinol (Lausanne); 2021; 12():753810. PubMed ID: 34675886
[TBL] [Abstract][Full Text] [Related]
11. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes.
Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ
Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
14. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
Scully KJ; Sherwood JS; Martin K; Ruazol M; Marchetti P; Larkin M; Zheng H; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Wexler DJ; Putman MS
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1444-e1454. PubMed ID: 34850006
[TBL] [Abstract][Full Text] [Related]
15. The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
Lind M; Tuomilehto J; Uusitupa M; Nerman O; Eriksson J; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Peltonen M; Pivodic A; Lindström J
PLoS One; 2014; 9(10):e109506. PubMed ID: 25285769
[TBL] [Abstract][Full Text] [Related]
16. Patterns of changes in fasting plasma glucose, hemoglobin A1c and the area under the curve during oral glucose tolerance tests in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.
Safari S; Amini M; Aminorroaya A; Feizi A
Acta Diabetol; 2021 Mar; 58(3):371-381. PubMed ID: 33084981
[TBL] [Abstract][Full Text] [Related]
17. The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia.
Jagannathan R; Sevick MA; Fink D; Dankner R; Chetrit A; Roth J; Buysschaert M; Bergman M
Acta Diabetol; 2016 Aug; 53(4):543-50. PubMed ID: 26794497
[TBL] [Abstract][Full Text] [Related]
18. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
[TBL] [Abstract][Full Text] [Related]
19. Prospective Test Performance of Nonfasting Biomarkers to Identify Dysglycemia in Children and Adolescents.
Vajravelu ME; Hirschfeld E; Gebremariam A; Burant CF; Herman WH; Peterson KE; Meijer JL; Lee JM
Horm Res Paediatr; 2023; 96(3):316-324. PubMed ID: 36380614
[TBL] [Abstract][Full Text] [Related]
20. Incidence of hyperglycaemic disorders in children and adolescents with obesity.
Chylińska-Frątczak A; Michalak A; Baranowska-Jaźwiecka A; Mianowska B; Szadkowska A
Pediatr Endocrinol Diabetes Metab; 2022; 28(4):274-280. PubMed ID: 36734390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
